Egypt’s Minapharm Secures $16.5 Million to Develop New Ebola Vaccine
The Egyptian pharmaceutical company Minapharm has received significant funding to advance research and production of a novel vaccine targeting the ongoing Ebola outbreak.
Results for "Minapharm"
2 stories found
CEPI Backs Minapharm's Ebola Vaccine with $16.5 Million as Congo Outbreak Grows
The Coalition for Epidemic Preparedness Innovations (CEPI) has provided up to $16.5 million to Egypt's Minapharm to develop an experimental Ebola vaccine, as a new outbreak of the Bundibugyo strain spreads in the Democratic Republic of Congo.